Discovery Research Lab automation systems Bio-containment Quality assurance / quality control Microbiology Stem cell / regenerative medicine
All dosage forms
Biopharmaceutical Nuclear medicine Chemical API
Oral solid dosage Inhalation devices Liquid organic compound Fill and finish
Formulation and analytical Development pilot plants Kilo labs Clinical trial Agrochemical R&D
Cold chain Distribution warehousing
Devices PET / CT, SPECT, MRI scanning
What our clients say
Scitech have the specialist knowledge and capabilities to ensure a compliant solution was delivered. Engaging with Scitech early in a project can ensure the correct approach is made and offer significant time and financial benefits to the overall result.
Dr S. J. Archibald , University of Hull
Scitech’s designers fully understood the nature and requirements of our business and engaged with the users to develop a modular design for the cell culture laboratories and GMP suites.The project was delivered successfully and ongoing support was provided to ensure the commissioning and functional operation of the laboratories.
Head of Facilities, Covance
The facility enables us to reconfigure the laboratories with minimal time and effort, in order to meet the changing needs of our work.
Laboratory Manager, B530 Discovery Park, Pfizer
I’ve used Scitech to act as consultants and provide commissioning services on two major radiopharmaceutical production facilities in Belfast and Cardiff. Scitech were a key partner in designing, commissioning and validating the facility and played a major part in successfully delivering a functioning facility.
Chris Marshall , Operations Director, Cardiff University
We needed a company to partner with us at all stages, from initial feasibility, through detailed facility design on the build programme and to the final commissioning. We have been impressed by the technical calibre of the Scitech team and their overall professional approach to keeping our project on time, specification and budget. We look forward to our facility opening in 2012 following a true partnership with the full Scitech team.
Mark Dean-Netscher, Chief Operating Officer, Penn Pharma